Anne Rosser is Professor of Clinical Neuroscience at Cardiff University and Honorary Consultant Neurologist at the University Hospital of Wales. She trained in Medicine at Cambridge University where she also undertook her PhD in Neuroscience. She has worked in the area of neurodegeneration since 1994 and has a special interest in Huntington’s disease (HD), in particular the development of new therapies for this and related neurodegenerative conditions. She directs the Cardiff University Brain Repair Group; leads the South Wales HD clinical service; and co-directs the Wales Brain Repair and Intracranial Neurotherapeutics (BRAIN) Unit, which aims to deliver therapeutics into the brain in neurological conditions. She led the FP7 Consortium Repair-HD between 2013 and 2018, and is currently Chair of the European HD Network.

Dr. Patrick Weydt is a board certified neurologist and certified neurogenetic counselor in the Department of Neurodegenerative Diseases and Gerontopsychiatry where he heads the Huntington’s Disease Clinic.  He has been involved in several studies and clinical trials for Huntington's disease, including LEGATO, PREDICT, REGISTRY and most recently ASO in HD. He has served as a member of the Scientific and Bioethical Advisory Board for EHDN and is currently the Co-Chair of the European HD Network.